Guardant Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	378.2	525.54	1,134	141.65	492.2
Short-Term Investments	823.4	314.44	35.1	869.58	440.55
Cash & Short-Term Investments	1,202	839.98	1,169	1,011	932.75
Cash Growth	43.05%	-28.12%	15.57%	8.41%	-48.03%
Receivables	137.85	110.25	88.78	97.26	97.65
Inventory	85.88	71.08	61.95	51.6	30.67
Prepaid Expenses	40.72	33.8	27.74	31.51	53.05
Total Current Assets	1,466	1,055	1,347	1,192	1,114
Property, Plant & Equipment	304.76	279.08	302.71	341.92	313.9
Long-Term Investments	6.5	16.1	106.6	43.3	737.43
Goodwill	77.26	3.29	3.29	3.29	3.29
Other Intangible Assets	25.92	6.76	8.98	11.73	14.21
Other Long-Term Assets	133.17	125.27	17.73	18.15	21.54
Total Assets	2,014	1,486	1,786	1,610	2,204
Accounts Payable	54.44	38.55	51.74	68.91	38.52
Accrued Expenses	169.86	122.35	72.74	55.79	42.5
Current Portion of Leases	27.68	29.21	27.95	21.88	12.86
Current Unearned Revenue	50.75	35.47	17.97	17.4	11.33
Other Current Liabilities	-	-	35.53	29.24	89.49
Total Current Liabilities	302.73	225.58	205.92	193.22	194.69
Long-Term Debt	1,504	1,143	1,140	1,137	1,135
Long-Term Leases	178.46	164.29	185.85	210.02	226.05
Long-Term Unearned Revenue	59.7	41.6	22.9	3.8	-
Other Long-Term Liabilities	68.07	51.23	73.11	5.38	3.93
Total Liabilities	2,113	1,625	1,628	1,550	1,559
Common Stock	0	0	0	0	0
Additional Paid-In Capital	2,900	2,444	2,304	1,742	1,658
Retained Earnings	-2,995	-2,578	-2,142	-1,662	-1,008
Comprehensive Income & Other	-4.85	-5.2	-3.68	-19.52	-4.76
Total Common Equity	-99.31	-139.65	158.68	60.18	645.01
Shareholders' Equity	-99.31	-139.65	158.68	60.18	645.01
Total Liabilities & Equity	2,014	1,486	1,786	1,610	2,204
Total Debt	1,710	1,336	1,354	1,369	1,374
Net Cash (Debt)	-508.54	-496.07	-185.13	-358.05	257.05
Net Cash Growth	-	-	-	-	-78.34%
Net Cash Per Share	-4.06	-4.04	-1.65	-3.50	2.54
Filing Date Shares Outstanding	131.17	123.42	121.71	102.66	101.87
Total Common Shares Outstanding	130.64	123.99	121.63	102.62	101.77
Working Capital	1,163	829.53	1,141	998.37	919.44
Book Value Per Share	-0.76	-1.13	1.30	0.59	6.34
Tangible Book Value	-202.49	-149.7	146.42	45.16	627.51
Tangible Book Value Per Share	-1.55	-1.21	1.20	0.44	6.17
Machinery	193.86	168.94	160.53	133.88	83.39
Construction In Progress	41.25	28.14	7.51	20.6	55.87
Leasehold Improvements	107.7	103.57	102.3	99.78	38.7

Updated Feb 19, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q